drugset / Trial / NCT04979611
The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
NaSingle-groupOpen-labelDiagnostic
Summary
The small insulinoma can not be detected by the CT or MRI. We use 68Ga-NOTA-exendin-4 positron emission tomography/computed tomography (PET/CT) to detect the insulinoma for the patient diagnosed with endogenous hyperinsulinemic hypoglycaemia. And the diagnostic value will be performed. A single dose of 37-111 Mega-Becquerel (MBq) 68Ga-NOTA-exendin-4 will be injected intravenously. Visual and semiquantitative method will be used to assess the PET/CT images.
Timeline
- Start
- 2020-08-01
- Primary completion
- 2025-08-01
- Completion
- 2025-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-NOTA-exendin-4 | Diagnostic / imaging agent | 37 mbq | Intravenous |
| Subject | 68Ga-NOTA-exendin-4 | Diagnostic / imaging agent | 111 mbq | Intravenous |